Trofosfamide
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Ixoten |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth (film-coated tablets) |
ATC code | L01AA07 (WHO) |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
22089-22-1 ![]() |
PubChem (CID) | 65702 |
UNII |
H64JRU6GJ0 ![]() |
KEGG |
D07252 ![]() |
ChEMBL |
CHEMBL462019 ![]() |
ECHA InfoCard | 100.040.686 |
Chemical and physical data | |
Formula | C9H18Cl3N2O2P |
Molar mass | 323.58 g/mol |
3D model (Jmol) | Interactive image |
| |
![]() ![]() |
Trofosfamide (INN) is a nitrogen mustard alkylating agent.
It is sometimes abbreviated "TRO".[1]
References
- ↑ Jahnke K, Thiel E, Bechrakis NE, et al. (December 2008). "Ifosfamide or trofosfamide in patients with intraocular lymphoma". J. Neurooncol. 93 (2): 213–7. doi:10.1007/s11060-008-9761-8. PMID 19099202.
This article is issued from Wikipedia - version of the 8/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.